Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events
Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events. // Pancreatology. – URL: https://www.sciencedirect.com/science/article/pii/S1424390326015905?dgcid=rss_sd_all
Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events. Pancreatology. https://www.sciencedirect.com/science/article/pii/S1424390326015905?dgcid=rss_sd_all
“Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events.” Pancreatology.
@article{article61442,
title = {Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events},
journal = {Pancreatology},
url = {https://www.sciencedirect.com/science/article/pii/S1424390326015905?dgcid=rss_sd_all}
}